309 related articles for article (PubMed ID: 15731068)
1. Characterization of a novel leucine-rich repeat protein antigen from group B streptococci that elicits protective immunity.
Seepersaud R; Hanniffy SB; Mayne P; Sizer P; Le Page R; Wells JM
Infect Immun; 2005 Mar; 73(3):1671-83. PubMed ID: 15731068
[TBL] [Abstract][Full Text] [Related]
2. Vaccination With a Latch Peptide Provides Serotype-Independent Protection Against Group B Streptococcus Infection in Mice.
Lin SM; Jang AY; Zhi Y; Gao S; Lim S; Lim JH; Song JY; Sullam PM; Rhee JH; Seo HS
J Infect Dis; 2017 Dec; 217(1):93-102. PubMed ID: 29106586
[TBL] [Abstract][Full Text] [Related]
3. Recombinant group B streptococcus Beta C protein and a variant with the deletion of its immunoglobulin A-binding site are protective mouse maternal vaccines and effective carriers in conjugate vaccines.
Yang HH; Madoff LC; Guttormsen HK; Liu YD; Paoletti LC
Infect Immun; 2007 Jul; 75(7):3455-61. PubMed ID: 17470542
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of group B protective surface protein, a new cell surface protective antigen of group B streptococci.
Erdogan S; Fagan PK; Talay SR; Rohde M; Ferrieri P; Flores AE; Guzmán CA; Walker MJ; Chhatwal GS
Infect Immun; 2002 Feb; 70(2):803-11. PubMed ID: 11796614
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and protective efficacy induced by self-amplifying mRNA vaccines encoding bacterial antigens.
Maruggi G; Chiarot E; Giovani C; Buccato S; Bonacci S; Frigimelica E; Margarit I; Geall A; Bensi G; Maione D
Vaccine; 2017 Jan; 35(2):361-368. PubMed ID: 27939014
[TBL] [Abstract][Full Text] [Related]
6. Identification of group B streptococcal Sip protein, which elicits cross-protective immunity.
Brodeur BR; Boyer M; Charlebois I; Hamel J; Couture F; Rioux CR; Martin D
Infect Immun; 2000 Oct; 68(10):5610-8. PubMed ID: 10992461
[TBL] [Abstract][Full Text] [Related]
7. Identification of a universal Group B streptococcus vaccine by multiple genome screen.
Maione D; Margarit I; Rinaudo CD; Masignani V; Mora M; Scarselli M; Tettelin H; Brettoni C; Iacobini ET; Rosini R; D'Agostino N; Miorin L; Buccato S; Mariani M; Galli G; Nogarotto R; Nardi-Dei V; Vegni F; Fraser C; Mancuso G; Teti G; Madoff LC; Paoletti LC; Rappuoli R; Kasper DL; Telford JL; Grandi G
Science; 2005 Jul; 309(5731):148-50. PubMed ID: 15994562
[TBL] [Abstract][Full Text] [Related]
8. Development of experimental GBS vaccine for mucosal immunization.
Gupalova T; Leontieva G; Kramskaya T; Grabovskaya K; Bormotova E; Korjevski D; Suvorov A
PLoS One; 2018; 13(5):e0196564. PubMed ID: 29727446
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of an antigen I/II family protein produced by group A Streptococcus.
Zhang S; Green NM; Sitkiewicz I; Lefebvre RB; Musser JM
Infect Immun; 2006 Jul; 74(7):4200-13. PubMed ID: 16790795
[TBL] [Abstract][Full Text] [Related]
10. A Safe and Stable Neonatal Vaccine Targeting GAPDH Confers Protection against Group B Streptococcus Infections in Adult Susceptible Mice.
Alves J; Madureira P; Baltazar MT; Barros L; Oliveira L; Dinis-Oliveira RJ; Andrade EB; Ribeiro A; Vieira LM; Trieu-Cuot P; Duarte JA; Carvalho F; Ferreira P
PLoS One; 2015; 10(12):e0144196. PubMed ID: 26673420
[TBL] [Abstract][Full Text] [Related]
11. Protection against experimental infection with group B streptococcus by immunization with a bivalent protein vaccine.
Larsson C; Stålhammar-Carlemalm M; Lindahl G
Vaccine; 1999 Feb; 17(5):454-8. PubMed ID: 10073723
[TBL] [Abstract][Full Text] [Related]
12. Temperature-Induced Self-Assembly of the Group B Streptococcus (GBS) Fusion Antigen GBS-NN.
Rose F; Roovers S; Fano M; Harloff-Helleberg S; Kirkensgaard JJK; Hejnaes K; Fischer P; Foged C
Mol Pharm; 2018 Jul; 15(7):2584-2593. PubMed ID: 29745668
[TBL] [Abstract][Full Text] [Related]
13. Immunological fingerprinting of group B streptococci: from circulating human antibodies to protective antigens.
Meinke AL; Senn BM; Visram Z; Henics TZ; Minh DB; Schüler W; Neubauer C; Gelbmann D; Noiges B; Sinzinger J; Hanner M; Dewasthaly S; Lundberg U; Hordnes K; Masoud H; Sevelda P; von Gabain A; Nagy E
Vaccine; 2010 Oct; 28(43):6997-7008. PubMed ID: 20732466
[TBL] [Abstract][Full Text] [Related]
14. [Recombinant fragments of conservative proteins of group B streptococci as a basis of specific vaccine].
Suvorov AN; Grabovskaia KB; Leont'eva GF; Meringova LF; Koroleva IN; Duplik NV; Totolian AA
Zh Mikrobiol Epidemiol Immunobiol; 2010; (2):44-50. PubMed ID: 20465000
[TBL] [Abstract][Full Text] [Related]
15. Deletion of repeats in the alpha C protein enhances the pathogenicity of group B streptococci in immune mice.
Gravekamp C; Rosner B; Madoff LC
Infect Immun; 1998 Sep; 66(9):4347-54. PubMed ID: 9712787
[TBL] [Abstract][Full Text] [Related]
16. Immunization with a recombinant BibA surface protein confers immunity and protects mice against group B Streptococcus (GBS) vaginal colonization.
Dos Santos NFB; da Silva LR; Costa FJMD; de Mattos DM; de Carvalho E; Ferreira LCS; Ferreira RCC
Vaccine; 2020 Jul; 38(33):5286-5296. PubMed ID: 32571719
[TBL] [Abstract][Full Text] [Related]
17. Cross-protection between group A and group B streptococci due to cross-reacting surface proteins.
Stâlhammar-Carlemalm M; Areschoug T; Larsson C; Lindahl G
J Infect Dis; 2000 Jul; 182(1):142-9. PubMed ID: 10882591
[TBL] [Abstract][Full Text] [Related]
18. Anti-Group B Streptococcus Glycan-Conjugate Vaccines Using Pilus Protein GBS80 As Carrier and Antigen: Comparing Lysine and Tyrosine-directed Conjugation.
Nilo A; Morelli L; Passalacqua I; Brogioni B; Allan M; Carboni F; Pezzicoli A; Zerbini F; Maione D; Fabbrini M; Romano MR; Hu QY; Margarit I; Berti F; Adamo R
ACS Chem Biol; 2015 Jul; 10(7):1737-46. PubMed ID: 25906283
[TBL] [Abstract][Full Text] [Related]
19. Group B streptococcal surface proteins as targets for protective antibodies: identification of two novel proteins in strains of serotype V.
Areschoug T; Stålhammar-Carlemalm M; Larsson C; Lindahl G
Infect Immun; 1999 Dec; 67(12):6350-7. PubMed ID: 10569749
[TBL] [Abstract][Full Text] [Related]
20. BibA induces opsonizing antibodies conferring in vivo protection against group B Streptococcus.
Santi I; Maione D; Galeotti CL; Grandi G; Telford JL; Soriani M
J Infect Dis; 2009 Aug; 200(4):564-70. PubMed ID: 19586417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
